News & Press Releases
Filter by:
An article by Edmund Daley, Pete Michaels, and Elizabeth Platonova about a new FINRA Regulatory Notice was published by Law360. The article discusses key changes that the notice presents, including shifting a significant burden to member firms to determine when the use of negative consent is appropriate.
Members Esteban Morales and Arameh O'Boyle published an article in Bloomberg Law predicting consumer class actions will increase due to evolving state and federal laws affecting telemarketing, online privacy, product labeling, and auto-renewal practices. The authors advise businesses to closely monitor these developments and strengthen arbitration clauses and class action waivers to reduce litigation risk.
Mintz has been named a finalist for three awards by LSPN. The awards celebrate excellence across the industry, from trailblazing individuals to firms redefining the boundaries of life sciences IP.
Bloomberg Law featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
Sige Gutman, Life Sciences Litigation Practice Chair, shared insights with IAM in an article about a decision by the US District Court for the District of Delaware which found that a gene therapy patent of RegenxBio and the Trustees of the University of Pennsylvania was ineligible and granted summary judgement in favor of Sarepta Therapeutics.
Law360 Pulse featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
